The Importance of Novel Therapies in Pediatric Patients With Bleeding Disorders

Dr Jain on the Importance of Novel Therapies in Pediatric Patients With Bleeding Disorders

Akshat Jain, MBBS, director, Inherited Bleeding Disorder and Thrombosis program, director, Sickle Cell Disease Program for Children and Young Adults, member, the clinical pediatric hematology/oncology, faculty, Stem Cell Transplantation, the Department of Pediatrics and Clinical Medicine, assistant professor, pediatrics, Hematology/Oncology Division, assistant professor, School of Public Health, Loma Linda University School of Medicine and Children’s Hospital, discusses the importance of novel therapies in the treatment of pediatric patients with beleeding disorders.

Videos

Akshat Jain, MBBS, discusses the importance of novel therapies in the treatment of pediatric patients with beleeding disorders.


Akshat Jain, MBBS

Articles

Dr Jain on the Importance of Novel Therapies in Pediatric Patients With Bleeding Disorders